Happy Independence Day! After many years of uncertainty, FDA has (finally!) recommended that trading partners use the Electronic Product Code Information Services (EPCIS) standard to

June 03, 2021 The following quote is attributed to Donald D. Ashley, J.D., Director of the Office of Compliance for FDA’s Center for Drug Evaluation

As you know, the FDA recently extended saleable returns verification until 2023. Please join Gateway Checker CEO and Founder Gary Lerner at the HDA 2020

FDA is issuing new guidance for immediate implementation in accordance with 21 CFR 10.115(g)(2). FDA is concerned that large volume of saleable returns coupled with

Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. As the industry works toward the law’s 2023 finish

The pharmaceutical industry struggles to ensure the integrity of its products as they are transferred between the different parts of the supply chain from contract

The 7th Annual Anti-Counterfeiting for Pharmaceuticals Summit takes a comprehensive approach to understand the latest regulations for the DSCSA to remain compliant and uphold quality

The FDA is announcing three public meetings entitled “Enhanced Drug Distribution Security under the Drug Supply Chain Security Act (DSCSA).” These public meetings are intended

The Distribution Management Conference (DMC) and Expo is HDA’s largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties

For over 15 years, LogiPharma has been the top resource for 300 senior supply chain executives within the Life Science industry. Our event focuses on